搜尋
COSCIENS Biopharma Inc
CSCI添加自選
2.720USD
0.0000.00%
收盤 07/02, 16:00（美東）報價延遲15分鐘
8.64M總市值
虧損本益比TTM
關於 COSCIENS Biopharma Inc 公司
COSCIENS Biopharma Inc.（前身爲 Aeterna Zentaris Inc.）是一家專業生物製藥公司，致力於開發和商業化各種藥品和診斷產品組合，包括專注於未滿足醫療需求領域的產品。其主要產品 macimorelin（Macrilen；Ghryvelin）是一種口服測試，用於診斷成人生長激素缺乏症 (AGHD)。該公司還致力於開發治療資產和專有提取技術，該技術用於生產可再生植物資源中的活性成分，用於藥妝產品（即燕麥β-葡聚糖和燕麥生物鹼，它們存在於 Aveeno 和 Burt's Bees 等護膚品品牌配方中），並正在開發爲潛在的營養保健品和/或藥品。
COSCIENS Biopharma Inc簡介
公司代碼CSCI
公司名稱COSCIENS Biopharma Inc
上市日期Dec 19, 1995
CEOMs. Anna Biehn
員工數量- -
證券類型Ordinary Share
年結日Dec 19
公司地址C/O Norton Rose Fulbright Canada Llp
城市TORONTO
上市交易所The Toronto Stock Exchange
國家Canada
郵編M5K 1E7
電話18439003201
網址https://www.cosciensbio.com/
公司代碼CSCI
上市日期Dec 19, 1995
CEOMs. Anna Biehn
COSCIENS Biopharma Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Ulrich Kosciessa
Dr. Ulrich Kosciessa
Director
Director
1.85K
--
Mr. Robert A. Seager
Mr. Robert A. Seager
Director
Director
--
--
Ms. Nicola Ammer
Ms. Nicola Ammer
Senior Vice President - Clinical Development, Chief Medical Officer
Senior Vice President - Clinical Development, Chief Medical Officer
--
--
Dr. Matthias Gerlach
Dr. Matthias Gerlach
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
--
--
Mr. Giuliano La Fratta
Mr. Giuliano La Fratta
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Mr. Michel Regnier
Mr. Michel Regnier
Senior Vice President, Chief Technology Officer
Senior Vice President, Chief Technology Officer
--
--
Mr. Ronald W. (Ronnie) Miller
Mr. Ronald W. (Ronnie) Miller
Director
Director
--
--
Mr. Peter H. Puccetti
Mr. Peter H. Puccetti
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. David Spear
Mr. David Spear
Director
Director
--
--
Mr. Anthony J. Giovinazzo
Mr. Anthony J. Giovinazzo
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Ulrich Kosciessa
Dr. Ulrich Kosciessa
Director
Director
1.85K
--
Mr. Robert A. Seager
Mr. Robert A. Seager
Director
Director
--
--
Ms. Nicola Ammer
Ms. Nicola Ammer
Senior Vice President - Clinical Development, Chief Medical Officer
Senior Vice President - Clinical Development, Chief Medical Officer
--
--
Dr. Matthias Gerlach
Dr. Matthias Gerlach
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
Senior Vice President - Manufacturing and Supply Chain, Managing Director - AEZS Germany
--
--
Mr. Giuliano La Fratta
Mr. Giuliano La Fratta
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Mr. Michel Regnier
Mr. Michel Regnier
Senior Vice President, Chief Technology Officer
Senior Vice President, Chief Technology Officer
--
--
常見問題
COSCIENS Biopharma Inc的前五大股東是誰？
COSCIENS Biopharma Inc的前五大股東如下：Dr. Ulrich Kosciessa
有多少機構持有COSCIENS Biopharma Inc(CSCI)的股份？
截至2026Q1，共有31家機構持有COSCIENS Biopharma Inc的股份，合計持有的股份價值約為257.26K，占公司總股份的8.08% 。與2025Q4相比，機構持股有所增加，增幅為-38426.00。